Results for tag: "Nonmelanoma Skin Cancer Drug"

Nonmelanoma skin cancer drugs are used to treat nonmelanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma. These drugs are typically administered topically, but may also be taken orally or injected. Commonly used drugs include imiquimod, fluorouracil, and diclofenac. These drugs work by targeting the abnormal cells that cause the cancer, while leaving healthy cells unharmed. The nonmelanoma skin cancer drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Novartis, Pfizer, Merck, and GlaxoSmithKline. Other companies include Sun Pharmaceuticals, Allergan, and Galderma. These companies are constantly developing new treatments and improving existing ones to provide better outcomes for patients. Show Less Read more